These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 23695421
1. Bone health and aldosterone excess. Ceccoli L, Ronconi V, Giovannini L, Marcheggiani M, Turchi F, Boscaro M, Giacchetti G. Osteoporos Int; 2013 Nov; 24(11):2801-7. PubMed ID: 23695421 [Abstract] [Full Text] [Related]
2. Hyperparathyroidism in patients with primary aldosteronism: cross-sectional and interventional data from the GECOH study. Pilz S, Kienreich K, Drechsler C, Ritz E, Fahrleitner-Pammer A, Gaksch M, Meinitzer A, März W, Pieber TR, Tomaschitz A. J Clin Endocrinol Metab; 2012 Jan; 97(1):E75-9. PubMed ID: 22013107 [Abstract] [Full Text] [Related]
3. Cross-Disciplinary Approach of Adrenal Tumors: Insights into Primary Aldosteronism-Related Mineral Metabolism Status and Osteoporotic Fracture Risk. Trandafir AI, Gheorghe AM, Sima OC, Ciuche A, Petrova E, Nistor C, Carsote M. Int J Mol Sci; 2023 Dec 11; 24(24):. PubMed ID: 38139166 [Abstract] [Full Text] [Related]
4. Bone and mineral metabolism in patients with primary aldosteronism: A systematic review and meta-analysis. Wang A, Wang Y, Liu H, Hu X, Li J, Xu H, Nie Z, Zhang L, Lyu Z. Front Endocrinol (Lausanne); 2022 Dec 11; 13():1027841. PubMed ID: 36387892 [Abstract] [Full Text] [Related]
5. Bone health among patients with primary aldosteronism: a systematic review and meta-analysis. Loh HH, Yee A, Loh HS. Minerva Endocrinol; 2019 Dec 11; 44(4):387-396. PubMed ID: 30482008 [Abstract] [Full Text] [Related]
6. Bone involvement in aldosteronism. Salcuni AS, Palmieri S, Carnevale V, Morelli V, Battista C, Guarnieri V, Guglielmi G, Desina G, Eller-Vainicher C, Beck-Peccoz P, Scillitani A, Chiodini I. J Bone Miner Res; 2012 Oct 11; 27(10):2217-22. PubMed ID: 22589146 [Abstract] [Full Text] [Related]
7. Factors affecting parathyroid hormone levels in different types of primary aldosteronism. Jiang Y, Zhang C, Ye L, Su T, Zhou W, Jiang L, Zhang Y, Wang W. Clin Endocrinol (Oxf); 2016 Aug 11; 85(2):267-74. PubMed ID: 26589237 [Abstract] [Full Text] [Related]
8. Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease. Tomaschitz A, Ritz E, Pieske B, Rus-Machan J, Kienreich K, Verheyen N, Gaksch M, Grübler M, Fahrleitner-Pammer A, Mrak P, Toplak H, Kraigher-Krainer E, März W, Pilz S. Metabolism; 2014 Jan 11; 63(1):20-31. PubMed ID: 24095631 [Abstract] [Full Text] [Related]
9. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C. Am J Hypertens; 1995 Sep 11; 8(9):884-93. PubMed ID: 8541003 [Abstract] [Full Text] [Related]
10. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G. J Am Geriatr Soc; 2007 May 11; 55(5):752-7. PubMed ID: 17493196 [Abstract] [Full Text] [Related]
11. Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults. Sayed-Hassan R, Abazid N, Koudsi A, Alourfi Z. Arch Osteoporos; 2016 May 11; 11():18. PubMed ID: 27126333 [Abstract] [Full Text] [Related]
12. Parathyroid hormone response to severe vitamin D deficiency is associated with femoral neck bone mineral density: an observational study of 405 women with hip-fracture. Di Monaco M, Castiglioni C, Tappero R. Hormones (Athens); 2016 Oct 11; 15(4):527-533. PubMed ID: 28222407 [Abstract] [Full Text] [Related]
13. Bone metabolism, density, and geometry in postmenopausal women with vitamin D insufficiency: a cross-sectional comparison of the effects of elevated parathyroid levels. Rødbro LL, Bislev LS, Sikjær T, Rejnmark L. Osteoporos Int; 2018 Oct 11; 29(10):2211-2218. PubMed ID: 29955908 [Abstract] [Full Text] [Related]
14. Association Between Aldosterone and Parathyroid Hormone Levels in Patients With Adrenocortical Tumors. Zavatta G, Di Dalmazi G, Altieri P, Pelusi C, Golfieri R, Mosconi C, Balacchi C, Borghi C, Cosentino ER, Di Cintio I, Malandra J, Pagotto U, Vicennati V. Endocr Pract; 2022 Jan 11; 28(1):90-95. PubMed ID: 34508903 [Abstract] [Full Text] [Related]
15. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. Duan Y, De Luca V, Seeman E. J Clin Endocrinol Metab; 1999 Feb 11; 84(2):718-22. PubMed ID: 10022443 [Abstract] [Full Text] [Related]
16. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China. Gao C, Qiao J, Li SS, Yu WJ, He JW, Fu WZ, Zhang ZL. Osteoporos Int; 2017 Jan 11; 28(1):211-218. PubMed ID: 27468899 [Abstract] [Full Text] [Related]
17. Improvement of bone turnover markers and bone mineral density following treatment of primary aldosteronism. Loh HH, Kamaruddin NA, Zakaria R, Sukor N. Minerva Endocrinol; 2018 Jun 11; 43(2):117-125. PubMed ID: 28001017 [Abstract] [Full Text] [Related]
18. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism. Palermo A, Naciu AM, Tabacco G, Falcone S, Santonati A, Maggi D, D'Onofrio L, Briganti SI, Castellitto D, Casini A, Pedone C, Lelli D, Fabbri A, Bilezikian JP, Napoli N, Pozzilli P, Manfrini S, Cesareo R. J Clin Endocrinol Metab; 2020 Jul 01; 105(7):. PubMed ID: 32271382 [Abstract] [Full Text] [Related]
19. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation. Ghannam NN, Hammami MM, Bakheet SM, Khan BA. Calcif Tissue Int; 1999 Jul 01; 65(1):23-8. PubMed ID: 10369729 [Abstract] [Full Text] [Related]
20. Analysis of the Increase in Bone Mineral Density After Surgical Treatment of Primary Hyperparathyroidism. Mendoza-Moreno F, Díez-Alonso M, Ovejero-Merino E, Sánchez-Gollarte A, Alvarado-Hurtado R, Matías-García B, Rodríguez-Pascual Á, Medina-Reinoso C, Ratia-Jiménez T, Hernández-Merlo F, Granell-Vicent J. J Clin Densitom; 2019 Jul 01; 22(2):171-178. PubMed ID: 30482495 [Abstract] [Full Text] [Related] Page: [Next] [New Search]